Stay updated on Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial

Sign up to get notified when there's something new on the Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A 403 Forbidden error page was added, displaying a minimal header and a Home link, indicating restricted access to the study record rather than a content update.
    Difference
    0.5%
    Check dated 2026-09-27T18:18:29.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The study page now renders a 403 Forbidden error, blocking access to the study record. As a result, the previous study content and documents listed on the page are no longer visible, replaced by the 403 page.
    Difference
    21%
    Check dated 2026-09-20T15:25:22.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Revision version updated to v3.6.6, replacing v3.6.5, indicating a minor site update without altering study data.
    Difference
    0.0%
    Check dated 2026-08-29T23:41:00.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5 on the site. This represents a minor platform update with no changes to the study details or on-page content.
    Difference
    0.0%
    Check dated 2026-08-08T23:20:18.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page version was updated from v3.6.3 to v3.6.4. This appears to be a maintenance update with minor fixes that do not change the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-07-25T16:56:39.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3 on the page, signaling a new version of the site's content or template. This is an internal update and does not alter the study details or user-visible information.
    Difference
    0.0%
    Check dated 2026-07-04T04:27:57.000Z thumbnail image

Stay in the know with updates to Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial page.